搜索结果: 'methocult media formulations for human hematopoietic cells serum containing'

Genome Editing of Human Primary T Cells Using CRISPR-Cas9

Investigating Metabolic Disease with Human Pluripotent Stem Cells

Genetic Stability of Human Pluripotent Stem Cells

Consequences of Culture-Acquired Genetic Changes in Human Pluripotent Stem Cells

Genome Editing of Human Pluripotent Stem Cells Using the ArciTect™ CRISPR-Cas9 System

Highly Efficient Single-Cell Human Pluripotent Stem Cell Cloning and Robust Cardiomyocyte Differentiation

Increased Single-Cell Cloning Efficiency of Human Pluripotent Stem Cells Using CloneR™

CRISPR-Cas9 Gene Editing Of CDK5RAP2 In Human Pluripotent Stem Cells, Derivation Of Genetically Stable Clonal Lines And Formation Of Cerebral Organoids

Using CRISPR/Cas9 to Model Stem Cell Organization and Dynamics

Genome Editing From Modeling Disease to Novel Therapeutics The use of genome editing tools to generate specific DNA variants in hPSCs provide more accurate modeling of human disease when differentiated into human-derived tissues. View this webinar presented by Dr. Chad Cowan at Harvard University, who discussed the design and use of TALENs or CRISPR/Cas9 systems with hPSCs and the applications of modified hPSCs, including disease modeling and gene therapy.

Scaling Biomimetic Culture of Pluripotent Stem Cells Hear from Dr. Maxime Feyeux, who discusses what the in vivo growth environment of pluripotent stem cells (PSCs) can teach us about in vitro culture. He summarizes some of the current challenges facing standard PSC culture technologies and shares a solution for mass producing high-quality PSCs for downstream applications.

Evaluation of Genome Editing